Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
van Bloemendaal, L
Stecca B, Mas C, Clement V, Zbinden M, Correa R, Piguet V
Alzheimer's Disease Neuroimaging Initiative, Shungu DC2
152 Proteomic profiling further identifies MDR1 upregulation as a critical driver of both intrinsic and acquired resistance to proteolysis-targeting chimeras (PROTACs), extending its relevance to emerging targeted protein degradation strategies
Access this article Similar content being viewed by others Data availability The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
